drugset / Trial / NCT00493038

Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial Rhinosinusitis

NCT00493038

Phase 4 Terminated 293 enrolled Bayer
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a clinical study organized to collect clinical data to better define the activity of some antimicrobials already marketed in Italy and in the rest of the world for the treatment of acute bacterial rhinosinusitis

Timeline

Start
2006-02
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin/Clavulanate Unknown 1000 mg Oral
Subject Moxifloxacin Small molecule 400 mg Oral